Can-Fite BioPharma
NYSE CANF · Ramat Gan, Israel
Works in Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
Can-Fite BioPharma is a clinical trial sponsor based in Ramat Gan, Israel, listed as NYSE CANF. It has 4 active clinical trials with 1,201 planned participants, across 13 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.
Trial track record · since 2021
Financials · NYSE CANF
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Can-Fite BioPharma
Can-Fite BioPharma is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 1,201 planned participants, in Dermatology, Genetic & rare, GI & liver, Immunology and other areas. Since 2021 it has completed 10 trials and stopped 0 early.
Can-Fite BioPharma is based in Ramat Gan, Israel and is listed as NYSE CANF. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Can-Fite BioPharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-02-18.
Approve Suite is not affiliated with Can-Fite BioPharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.